[{"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206884"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-190", "33342-191", "33342-192", "33342-193"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["ec147040-b267-4905-b311-09ebce2080b4"], "spl_set_id": ["c86a3c45-c906-46c9-9f7b-6c3d89bbe48f"], "package_ndc": ["33342-190-07", "33342-190-10", "33342-190-12", "33342-190-44", "33342-191-07", "33342-191-10", "33342-191-12", "33342-191-44", "33342-192-07", "33342-192-10", "33342-192-12", "33342-192-44", "33342-193-07", "33342-193-10", "33342-193-12", "33342-193-44"], "is_original_packager": [true], "upc": ["0333342190079", "0333342190109", "0333342191076", "0333342193070", "0333342193100", "0333342192103", "0333342192073", "0333342191106"], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0509-2021", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx Only NDC 33342-192-07 Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India", "product_quantity": "33 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BAD62005A"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0276-2018", "product_description": "Medline Catheter Insertion Kit, Sterile. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "4,100 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDINSERTKIT; Lots: 17SB3347;  175B1052;  16JB3251;  16IB2940;  17CB4925", "more_code_info": ""}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0966-2016", "product_description": "The Store Thin and Slim Thermogenic Fat Burner Dietary Supplement packaged in 90 capsule containers. Distributed by The Store 2050 E. 6200 S., Holladay, UT 84121, The Store Holliday, 4695 S.Holladay Blvd, Holladay, UT 84117, The Store Midway, 42 W. Main Street, Midway, UT 84049.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "UPC 020025500095"}, {"status": "Terminated", "city": "La Jolla", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA200063"], "brand_name": ["CONTRAVE"], "generic_name": ["NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Nalpropion Pharmaceuticals LLC"], "product_ndc": ["51267-890"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE", "NALTREXONE HYDROCHLORIDE"], "rxcui": ["1551468", "1551474"], "spl_id": ["8e7e5582-7a35-4ec7-85e7-b88a98d1bd23"], "spl_set_id": ["485ff360-32c8-11df-928b-0002a5d5c51b"], "package_ndc": ["51267-890-99", "51267-890-07"], "is_original_packager": [true], "upc": ["0351267890997"], "unii": ["ZG7E5POY8O", "Z6375YW9SF"]}, "product_type": "Drugs", "event_id": "81505", "recalling_firm": "Orexigen Therapeutics, Inc.", "address_1": "3344 N Torrey Pines Ct Ste 200", "address_2": "", "postal_code": "92037-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the United States", "recall_number": "D-0219-2019", "product_description": "Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99", "product_quantity": "18,895 bottles", "reason_for_recall": "Container packaging defect.", "recall_initiation_date": "20181005", "center_classification_date": "20181106", "termination_date": "20191115", "report_date": "20181114", "code_info": "Lot #: ZYCY, Exp. 04/11/2021", "more_code_info": ""}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10030341 11/24/2019, 10031102 12/6/2019,  10031555 Exp. 12/18/2019,  10031554 Exp. 12/18/2019,  10031803 Exp. 12/23/2019,  10031776 Exp. 12/22/2019,  10032266 Exp. 12/30/2019,  10032267 Exp. 12/30/2019,  10032321  Exp. 12/31/2019,  10032320 Exp. 12/31/2019,  10032544 Exp. 1/5/2020,  10032515 Exp. 1/5/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 1000 mcg/100 mL (10 mcg/mL) in 0.9% Sodium Chloride 100 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1250-75", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0571-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "6 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 09302013@6", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Phenylephrine/Tropicamide 2.5 %/1 % ophthalmic solution, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-439-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020062"], "brand_name": ["CARDIZEM CD"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Bausch Health US LLC"], "product_ndc": ["0187-0795", "0187-0796", "0187-0797", "0187-0798", "0187-0799"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830795", "830798", "830801", "830803", "830837", "830839", "830845", "830847", "830861", "830863"], "spl_id": ["34176cb9-d505-1c88-e063-6394a90aa131"], "spl_set_id": ["1042fa13-e6af-46b9-8008-6c941f0978b1"], "package_ndc": ["0187-0795-30", "0187-0795-42", "0187-0795-49", "0187-0796-30", "0187-0796-42", "0187-0796-49", "0187-0796-50", "0187-0797-30", "0187-0797-42", "0187-0797-49", "0187-0798-30", "0187-0798-42", "0187-0799-42"], "is_original_packager": [true], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "82021", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0489-2019", "product_description": "Cardizem CD (diltiazem HCl) capsules, 240 mg, packaged in a) 30-count bottles (NDC 0187-0797-30); and b) 90-count bottles (NDC 0187-0797-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.", "product_quantity": "390 bottles", "reason_for_recall": "Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.", "recall_initiation_date": "20190130", "center_classification_date": "20190214", "termination_date": "20200708", "report_date": "20190220", "code_info": "Lots: a) 18J019P, Exp 08/2020; b) 18J028P, Exp 08/2020"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0644-2016", "product_description": "MYCAMINE (micafungin sodium) 150MG, Packaged in 150ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "10 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: 24-Sep-15, 27-Sep-15"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89945", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0773-2022", "product_description": "Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical, Preferred Pharmaceuticals, Inc., The Physicians Solutions, NDC 68788-7918-01", "product_quantity": "528 bottles", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.", "recall_initiation_date": "20220324", "center_classification_date": "20220415", "termination_date": "20231025", "report_date": "20220427", "code_info": "Lots: E1220B, Exp.: 01/31/2023; F0220M, Exp.: 3/31/2023; F2320A, Exp.: 3/31/2023; F3020M, Exp.: 3/31/2023; G0920Q, Exp.: 3/31/2023; C0821M, Exp.: 1/31/2024; J1920, Exp.: 5/31/2023; E2421j, Exp.: 4/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89556", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "210 W Main St", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0568-2022", "product_description": "Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.", "product_quantity": "5,477 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20220215", "center_classification_date": "20220217", "termination_date": "20221025", "report_date": "20220223", "code_info": "Lot #: 19B064A, Exp. Date 03/2022"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "6 preparations", "code_info": "All product compounded between May 14, 2015 and May 27, 2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "TPN 3:1, 1050 mL  Bags, Qty: 6, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Sterile Water; Electrolytes KCL, K Phos, MgSO4, NaCl, Zinc Cl, Ca Gluconate; Vitamins, trace elements and medications Trace Ele.-Ped, Infuvite Pediat, Carnitor, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1163-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71656", "recalling_firm": "Kremers Urban Pharmaceuticals, Inc.", "address_1": "1101 C Ave W", "address_2": "N/A", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1236-2015", "product_description": "Nitroglycerin Transdermal System 0.2 mg/hr (10 cm2), For Transdermal Use Only, 30 Systems (patches) per box, Rx Only,  Manufactured for: Kremers Urban Pharmaceuticals Inc., Princeton, NJ, 08540, USA, By LTS Lohmann Therapie Systeme AG, Anderach, Federal Republic of Germany, NDC 62175-123-01", "product_quantity": "16,832 Boxes", "reason_for_recall": "Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing.", "recall_initiation_date": "20150707", "center_classification_date": "20150714", "termination_date": "20160212", "report_date": "20150722", "code_info": "Lot #: 5267605, Exp 08/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Attleboro", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68136", "recalling_firm": "Mangiacotti", "address_1": "117 Pleasant Street", "address_2": "N/A", "postal_code": "02703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1306-2014", "product_description": "Mangiacotti\t - Clementine Hand Sanitizer Spray, alcohol free, 0.5 fl Oz. 15 mL spray bottle, UPC 870678005337, Active Ingredient Benzalkonium Chloride 0.1%, Dist By: Mangiacotti, Attleboro, MA 02703.", "product_quantity": "N/A", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:  Elevated counts of bacteria was found, Serratia liquefaciens.", "recall_initiation_date": "20131227", "center_classification_date": "20140506", "termination_date": "20160429", "report_date": "20140514", "code_info": "Lot Code:  13350"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0219-2016", "product_description": "ESTRIOL (E3) : ESTRADIOL (E2)  (Estradiol (E2) Trit (Yellow)) : TESTO (Testosterone USP) W/V (weight/volume) 2.0: 0.1: 0.5MG/ML Transdermal cream, dispensed in 5 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "9 (5mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 12102014:82@10, Exp 6/8/2015"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0688-2019", "product_description": "Dr. King's SafeCare Rx Chicken Pox Symptom Relief Children High Potency Homeopathic Formula for Professional Use Only, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955782520, NDC 57955-7825-2", "product_quantity": "15 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 042616D Exp. 04/19"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090509"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-525", "55111-526", "55111-527"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["198377", "198378", "313190"], "spl_id": ["706bafff-d629-291c-5ce5-83d74a638860"], "spl_set_id": ["61dee012-43af-0e9a-3843-9b9b91e022c4"], "package_ndc": ["55111-525-30", "55111-525-01", "55111-525-05", "55111-525-79", "55111-525-78", "55111-526-30", "55111-526-01", "55111-526-05", "55111-526-79", "55111-526-78", "55111-527-30", "55111-527-01", "55111-527-05", "55111-527-79", "55111-527-78"], "is_original_packager": [true], "upc": ["0355111527015", "0355111525011", "0355111526018"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "93622", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0219-2024", "product_description": "Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01", "product_quantity": "8,280 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.", "recall_initiation_date": "20231215", "center_classification_date": "20240105", "termination_date": "20240916", "report_date": "20240117", "code_info": "Lot# C2307275; Exp.  January 2026", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0256-2020", "product_description": "S-VIT A PALMITATE 50,000 IU/ML CORN OIL, Rx Only, 10ml dropper bottle. Red Mountain Compounding Rx.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S07292019DH@16, Exp 10/29/19"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206937"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-443", "13668-473"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["2532159", "2532163"], "spl_id": ["f8d8c930-c8f9-4186-92fa-6f7a5dabe083"], "spl_set_id": ["dcebc7cf-6f95-4f7a-a22b-c7d2e0f04d74"], "package_ndc": ["13668-443-74", "13668-443-10", "13668-443-01", "13668-443-30", "13668-443-91", "13668-473-10", "13668-473-74", "13668-473-30", "13668-473-01", "13668-473-91"], "is_original_packager": [true], "upc": ["0313668443301", "0313668473308"], "unii": ["I9W7N6B1KJ"]}, "product_type": "Drugs", "event_id": "96983", "recalling_firm": "Torrent Pharma Inc.", "address_1": "106 Allen Rd Ste 305", "address_2": "N/A", "postal_code": "07920-3851", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0455-2025", "product_description": "Fluoxetine Tablets, USP, 20 mg,  30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920.  NDC: 13668-473-30", "product_quantity": "3672 Bottles", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.", "recall_initiation_date": "20250527", "center_classification_date": "20250602", "report_date": "20250611", "code_info": "Lot# BDX6K001; Exp. Date 06/30/2025"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0377-2016", "product_description": "Zinc Sulfate (Elemental) Injection, 10mg/mL, 30 mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "74 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076972"], "brand_name": ["ONDANSETRON"], "generic_name": ["ONDANSETRON HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-373", "63323-374"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["ONDANSETRON HYDROCHLORIDE"], "rxcui": ["283504", "1740467"], "spl_id": ["83824969-e116-40d6-8940-ff134a4f16c0"], "spl_set_id": ["e0050959-c14c-41b6-9a92-fadc5f6feff3"], "package_ndc": ["63323-373-00", "63323-373-02", "63323-374-20"], "is_original_packager": [true], "upc": ["0363323374204", "0363323373009"], "unii": ["NMH84OZK2B"]}, "product_type": "Drugs", "event_id": "63451", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide Including Puerto Rico", "recall_number": "D-0296-2015", "product_description": "ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL),  For IM or IV Use, Single Dose 2 mL Vials, Rx only.  APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02", "product_quantity": "184,550 Vials", "reason_for_recall": "Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.", "recall_initiation_date": "20120927", "center_classification_date": "20141210", "termination_date": "20141212", "report_date": "20141217", "code_info": "Lot 6003930, exp. date 04/2014"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0997-2016", "product_description": "MB 12/HXB 12/FA/P5P/(LIDO 0.1 %), 2MG/2MCi/20MG/6.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01182016:46@7, Exp.04/17/2016; Lot #: 02192016    60@29, Exp. 05/19/2016; Lot #: 04082016:83@53; Exp.  07/11/2016; Lot #: 04202016:61@66, Exp.07/19/2016."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0960-2023", "product_description": "PHENYLephrine, 10mg/250ml added to 0.9% sodium chloride, 40mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043,  NDC: 72196-6058-1.", "product_quantity": "7518 bag", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239333, Exp. 7/11/2023; 36-240005, Exp. 7/13/2023; 36-240800, Exp. 7/17/2023; 36-241139, 36-241140, Exp. 7/19/2023; 36-241913, Exp.7/23/2023; 36-242557, 36-242560, Exp. 7/25/2023; 36-244880, 36-244883, 36-244884, 36-244885, Exp. 8/1/2023; 36-246717, 36-246718, 36-246719, 36-246720, Exp.8/6/2023; 36-247598, 36-247599, Exp. 8/9/2023; 36-247828, 36-247829, 36-247830, 36-247831, Exp. 8/10/2023; 36-249233, 36-249234, 36-249235, 36-249344, Exp. 8/17/2023; 36-255964, Exp. 9/10/2023"}, {"status": "Ongoing", "city": "Columbia", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96754", "recalling_firm": "Apollo Care, LLC", "address_1": "3801 Mojave Ct Ste 101", "address_2": "N/A", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MO", "recall_number": "D-0409-2025", "product_description": "FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Injection (For Epidural Use Only), Sterile, Single-Use Container, Rx Only, Apollocare, 3801 Mojave Ct, Ste 101, Columbia, MO 65202, NDC 71170-950-25", "product_quantity": "440 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250415", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot AC-016878, exp date 6/16/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0532-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Heartburn Reliever, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955502227, NDC 57955-5022-2", "product_quantity": "2045 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 020817H Exp. 02/20; 030816A Exp. 03/19; 050216B Exp. 05/19; 061616B Exp. 06/19; 072115C Exp. 07/18"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0541-2021", "product_description": "RISPERIDONE 1MG/ML 30ML; NDC/UPC 50458059601; RX; SOLUTION (USUALLY NOT OTIC, OPTH, NASAL DROPS)", "product_quantity": "39 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KHB2701"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91353", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0093-2023", "product_description": "Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4", "product_quantity": "22,027 bottles", "reason_for_recall": "Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.", "recall_initiation_date": "20221221", "center_classification_date": "20221228", "termination_date": "20251008", "report_date": "20230104", "code_info": "Lot# TA4844, Exp 03/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80847", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1141-2018", "product_description": "Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 10 mg/320 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by:  Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-325-30", "product_quantity": "169,200 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180817", "center_classification_date": "20180828", "report_date": "20180905", "code_info": "Batch: BBX2D025,  BBX2D026,  BBX2E001,  BBX2E002,  BBX2E003,  BBX2E004,  BBX2E005,  BBX2D003,  BBX2D004,  BBX2D005,  BBX2D006,  BBX2D007,  BBX2D008,  BBX2D015,  BBX2D016,  BBX2D017,  BBX2D018,  BBX2D019,  BBX2D020,  BBX2D021,  BBX2D022,  BBX2D023,  BBX2D024,  BBX2D001,  BBX2D002,  BBX2D009,  BBX2D010,  BBX2D011,  BBX2D012,  BBX2D013,  BBX2D014,  BBX2C007"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0538-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Skin Irritations & Itch Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955516828, NDC 57955-5168-2", "product_quantity": "2177 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 010818C Exp. 01/20; 030916S Exp. 08/18; 041117K Exp. 04/19; 072216M Exp. 07/19; 083115F Exp. 08/18"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64338", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-182-2013", "product_description": "Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b) 90-count tablets per bottle (NDC 68462-392-90), Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430.", "product_quantity": "591,972 bottles", "reason_for_recall": "Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).", "recall_initiation_date": "20130213", "center_classification_date": "20130305", "termination_date": "20141009", "report_date": "20130313", "code_info": "02122956, 02123226, 02123269, 02123480, 02123481,  02122933, 02122955, 02123062, 02123075, 02123085,  02123114, 02123115, 02123124, 02123125, 02123189,  02123199, 02123205, 02123219, 02123253, 02123270,  02123289, 02123295, 02123320, 02123333, 02123343,  02123349, 02123411, 02123421, 02123431, Exp 09/14 and 10/14"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211798"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-613", "67877-614"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["e9f19258-b62c-471d-82c4-1e2bdc030833"], "spl_set_id": ["72f25135-1333-4e52-83f5-7df7d90e68bb"], "package_ndc": ["67877-613-15", "67877-613-05", "67877-614-15", "67877-614-05"], "is_original_packager": [true], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "86859", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MI", "recall_number": "D-0173-2021", "product_description": "Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15.", "product_quantity": "1200 bottles", "reason_for_recall": "Failed Dissolution Specifications; Out of Specification (low) results were obtained.", "recall_initiation_date": "20201124", "center_classification_date": "20201222", "termination_date": "20230411", "report_date": "20201209", "code_info": "Lot #19143017, Exp. 05/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0755-2016", "product_description": "Fentanyl Citrate 1.275 mg/ml/Baclofen 150 mcg/ml/Bupivacaine HCL 20 mg/ml/  Clonidine HCL 450 mcg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78708", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0156-2018", "product_description": "Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe, Total Volume 10 mL, Rx only,  SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0600-12", "product_quantity": "1248 syringes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.", "recall_initiation_date": "20171207", "center_classification_date": "20180105", "termination_date": "20190501", "report_date": "20180117", "code_info": "Lot#: 20171013@30,  Exp 12/27/2017", "more_code_info": ""}, {"country": "United States", "city": "Earth City", "address_1": "13480 Lakefront Dr", "reason_for_recall": "Labeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description.  Tablet strength is 10 mg.", "address_2": "", "product_quantity": "484,236 cartons", "code_info": "Lot # 130251, 130252, 130253 Exp date: 11/14", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "MO", "product_description": "Walmart Amlodipine Besylate Tablets, USP 10 mg, Rx only, 30 tablets, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY. Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ. Distributed by: Wal-Mart Stores, Inc., Bentonville, AR.  Packaged by: Legacy Pharmaceutical Packaging, LLC, Earth City, MO. NDC 68645-445-70.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "Legacy Pharmaceutical Packaging LLC", "recall_number": "D-319-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "64974", "termination_date": "20140213", "more_code_info": "", "recall_initiation_date": "20130422", "postal_code": "63045-1516", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS Tablet may be potentially mislabeled as    MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 65162066850, Pedigree: AD62979_1, EXP: 5/23/2014;  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD62986_1, EXP: 5/23/2014;  LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), NDC 00054002025, Pedigree: AD21790_25, EXP: 5/1/2014;  OMEGA-3 FATTY ACID, Capsule, 100", "address_2": "", "product_quantity": "1,249 Tablets", "code_info": "LACTOBACILLUS Tablet has the following codes    Pedigree: AD62986_10, EXP: 5/23/2014;  Pedigree: AD62992_1, EXP: 5/23/2014;  Pedigree: AD22865_1, EXP: 5/2/2014;  Pedigree: W003624, EXP: 1/31/2014;  Pedigree: W003622, EXP: 6/25/2014;  Pedigree: W003623, EXP: 10/31/2013.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 64980012950", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-700-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0992-2020", "product_description": "Cholecalciferol (Vitamin D3) Injection, VITAMIN D3 [P] 1,000 IU/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0210-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 04082019+51930, Exp 4/8/2020; 09092019+52891, Exp 8/12/2020"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "78021", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1169-2017", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches  Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5552-3", "product_quantity": "321,900 patches", "reason_for_recall": "Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.", "recall_initiation_date": "20170830", "center_classification_date": "20170918", "termination_date": "20200124", "report_date": "20170927", "code_info": "Lot: 80433 Exp. 08/17", "more_code_info": ""}, {"country": "United States", "city": "Plano", "address_1": "2743 W 15th St", "reason_for_recall": "Presence of Particulate Matter; preservative may not have dissolved completely or precipitated out of product", "address_2": "", "product_quantity": "15 vials", "code_info": "Lot# 10082014@10", "center_classification_date": "20150326", "distribution_pattern": "TX", "state": "TX", "product_description": "Hydroxocobalamin Injection Solution 1 mg/mL Inj., Rx, compounded by American Specialty Pharmacy, Plano, TX 75075 214-919-2090.  NDC 99999-9994-27", "report_date": "20150401", "classification": "Class II", "openfda": {}, "recalling_firm": "American Specialty Pharmacy", "recall_number": "D-0427-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "70013", "termination_date": "20161123", "more_code_info": "", "recall_initiation_date": "20141212", "postal_code": "75075-7525", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1638-2019", "product_description": "BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC:  70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0137-03", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018044"], "brand_name": ["CALCITRIOL"], "generic_name": ["CALCITRIOL"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-239", "63304-240", "63304-241"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CALCITRIOL"], "rxcui": ["308867", "308868", "313932"], "spl_id": ["ccc0e02b-bd1e-45f2-9256-6933ac193518"], "spl_set_id": ["66a69351-5b09-4368-a9fa-acf81b5ad882"], "package_ndc": ["63304-239-30", "63304-239-01", "63304-240-01", "63304-241-59"], "is_original_packager": [true], "upc": ["0363304239010", "0363304240016"], "nui": ["M0004229", "N0000175908"], "pharm_class_cs": ["Cholecalciferol [CS]"], "pharm_class_epc": ["Vitamin D3 Analog [EPC]"], "unii": ["FXC9231JVH"]}, "product_type": "Drugs", "event_id": "80326", "recalling_firm": "Validus Pharmaceuticals, Inc.", "address_1": "119 Cherry Hill Rd Ste 310", "address_2": "N/A", "postal_code": "07054-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. nationwide", "recall_number": "D-1170-2018", "product_description": "Calcitriol Oral Solution, 1 mcg/mL, 15 mL bottle, Rx Only, Distributed by: Ranbaxy Pharmaceuticals Inc. Jacksonville, FL 32257 USA, NDC 63304-241-59", "product_quantity": "7864 bottles", "reason_for_recall": "Subpotency: lower than expected potency result was obtained at the 18 month stability time point.", "recall_initiation_date": "20180615", "center_classification_date": "20180905", "termination_date": "20210122", "report_date": "20180905", "code_info": "RV1602RB, Exp 07/2019; RV1604RB, Exp 9/2019; RV1605RB, Exp 10/2019"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-970-2013", "product_description": "HYDROXYPROGESTERONE CAPROATE  250 MG/ML OIL INJ SOLN, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "05032013@4, 05222013@13", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0282-2016", "product_description": "Testosterone EO-Pro-Cyp 220 (220 mg/mL) 30 mL Multi-Dose Vial, For Deep IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72653, NDC 62295-2169-06", "product_quantity": "1,386 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20151006@46 BUD: 12/7/2015, 20151607@40 BUD: 1/12/2016, 20152005@32 BUD: 11/16/2015, 20152304@28 BUD: 10/20/2015, 20152304@5 BUD: 10/20/2015, 20152606@2 BUD: 12/22/2015, 20152907@16 BUD: 1/23/2016"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0305-2022", "product_description": "PHENYLepherine HCL in 0.9% Sodium Chloride, 20 mg per 250 mL (80 mcg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-701-01.", "product_quantity": "18,948 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21086/BQW 14-Dec-21  S21149/BTH 23-Jan-22  S21159/BTQ 30-Jan-22  S21265/BXI 3-Apr-22  S21305/BYU 24-Apr-22  S21311/BZA 26-Apr-22", "more_code_info": ""}, {"status": "Terminated", "city": "Parker", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84437", "recalling_firm": "OraLabs, Incorporated", "address_1": "18685 Plaza Dr", "address_2": "N/A", "postal_code": "80134-9061", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0624-2020", "product_description": "Petroleum jelly (White Petrolatum) USP 100%, packaged in a) 1 oz tube (UPC 1182298884), b) 2.5 oz tube (UPC 1182298541), Distributed by Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011", "product_quantity": "N/A", "reason_for_recall": "Cross contamination with other products: undeclared contaminants of phenol and camphor in petroleum jelly tubes.", "recall_initiation_date": "20191125", "center_classification_date": "20191219", "termination_date": "20210127", "report_date": "20191218", "code_info": "Lot #: a) 44660922 Exp. 09/22; b) 44771122, Exp. 11/22", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078155"], "brand_name": ["SIMVASTATIN"], "generic_name": ["SIMVASTATIN"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-004", "16729-005", "16729-006", "16729-007", "16729-156"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIMVASTATIN"], "rxcui": ["198211", "200345", "312961", "312962", "314231"], "spl_id": ["1d86e518-c8d2-f3a7-e063-6394a90ab551"], "spl_set_id": ["871251c0-36a1-4a32-9eab-ff6c1e925ca9"], "package_ndc": ["16729-005-10", "16729-005-12", "16729-005-15", "16729-005-17", "16729-006-10", "16729-006-12", "16729-006-15", "16729-006-17", "16729-007-10", "16729-007-12", "16729-007-15", "16729-007-17", "16729-156-10", "16729-156-15", "16729-156-17", "16729-004-10", "16729-004-12", "16729-004-15", "16729-004-17"], "is_original_packager": [true], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["AGG2FN16EV"], "upc": ["316729004152", "316729004176"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0409-2023", "product_description": "Simvastatin Tablets, USP, 10 mg, Rx Only, Packaged as: a) 90-count bottle NDC 16729-004-15, UPC 3 16729 00415 2; b) 1,000-count bottle NDC 16729-004-17, UPC 3 16729 00417 6; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA", "product_quantity": "291,378 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2106923, Exp. Date 9/30/2023; R2101544, Exp. Date 10/31/2023; R2200732, Exp. Date 5/31/2025; b) P2101634, Exp. Date 2/28/2023; P2102370, Exp. Date 3/31/2023;  P2102321, Exp. Date 3/31/2023;  P2102411, Exp. Date 3/31/2023;  P2102454, Exp. Date 3/31/2023;  P2103991, Exp. Date 5/31/2023;  R2100954, Exp. Date 6/30/2023;  R2100947, Exp. Date 6/30/2023;  R2100951, Exp. Date 6/30/2023;  P2106242, Exp. Date 8/31/2023;  P2106928, Exp. Date 9/30/2023;  P2107424, Exp. Date 9/30/2023; R2101542, Exp. Date 10/31/2023; R2101543, Exp. Date 10/31/2023; R2200026, Exp. Date 11/30/2023; R2200414, Exp. Date 2/29/2024; R2200416, Exp. Date 2/28/2025; R2200586, Exp. Date 4/30/2025; R2200679, Exp. Date 5/31/2025; R2200824, Exp. Date 5/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0714-2019", "product_description": "Dr. King's SafeCare Rx Anti-Aging & Wrinkles For Women, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955614722, NDC 57955-6148-2", "product_quantity": "338 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 032316A Exp. 03/19; 010617B Exp. 01/20"}, {"status": "Terminated", "city": "Grand Prairie", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65774", "recalling_firm": "Herbal Give Care Llc", "address_1": "1901 S Great Southwest Pkwy Ste 101", "address_2": "N/A", "postal_code": "75051-3557", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.", "recall_number": "D-1333-2014", "product_description": "Esbelder Fem Mezcla con L-Carnitina Suplemento Alimenticio,30 capsule bottle, Hecho en Mexico: Soluciones HGC S. de R.L. de C.V. Av. Independencia #1060 Fracc.  La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136.     UPC 7502011000251", "product_quantity": "347 bottles of 30 capsules each", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di-  Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.", "recall_initiation_date": "20130719", "center_classification_date": "20140520", "termination_date": "20150821", "report_date": "20140528", "code_info": "All lots"}, {"status": "Terminated", "city": "Grand Rapids", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80893", "recalling_firm": "Hellolife", "address_1": "4460 44th St SE Ste C600", "address_2": "N/A", "postal_code": "49512-4150", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Algeria  Australia  Belgium  Brazil  Bulgaria  Canada  Colombia  Croatia  Cyprus  Czech Republic  Denmark  Dominican Republic  Ecuador  Estonia  French Polynesia  Greece  Guadeloupe  Guam  Hong Kong  Hungary  India  Ireland  Israel  Italy  Latvia  Lithuania  Martinique  Mexico  Monaco  Netherlands  New Zealand  Norway  Peru  Poland  Portugal  Romania  Russia  Russian Federation  Saudi Arabia  Senegal  Serbia  Slovakia  Slovakia (Slovak Republic)  Slovenia  Swaziland  Sweden  Switzerland  Taiwan  Turkey  United Kingdom", "recall_number": "D-1202-2018", "product_description": "Thyroveev, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512.  NDC: 49726-025-02", "product_quantity": "370 bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia", "recall_initiation_date": "20180823", "center_classification_date": "20180917", "termination_date": "20210127", "report_date": "20180919", "code_info": "Lot: TV/030717F, exp 7/2019"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090295"], "brand_name": ["METFORMIN HYDROCHLORIDE EXTENDED RELEASE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["72789-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["3143f509-5529-ee8b-e063-6294a90aeed3"], "spl_set_id": ["14f3091c-f243-4364-b433-727c7d4ef8d5"], "package_ndc": ["72789-009-30", "72789-009-60", "72789-009-90", "72789-009-93"], "original_packager_product_ndc": ["49483-623"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "86600", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AK, AZ, CA, CO, FL, GA, ID, IL, IN, KY, MN, NC, NY, OK, OR, WI", "recall_number": "D-0059-2021", "product_description": "metformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 72789-009-60; c) 90 tablets NDC: 72789-009-90; d) 180 tablets NDC: 72789-009-93 bottles, Rx only, Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127", "product_quantity": "1683 bottles", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)", "recall_initiation_date": "20201006", "center_classification_date": "20201102", "termination_date": "20211022", "report_date": "20201111", "code_info": "Lots:   a) B20D23, B20D67 Exp. 07/31/21, C20D55 Exp. 12/31/21;   b) A20D92, A20F59, B20C16 Exp. 07/31/21, C20D63, D20A45, D20C80 Exp. 12/31/21, G20D46, I20C57 Exp. 04/30/22;  c) A20D90, A20E77, A20F69, B20F43 Exp. 07/31/21, C20B14, D20A41 Exp. 12/31/21, I20D94, I20E56, J20A28 Exp. 04/30/22;  d) B20B96 Exp. 07/31/21, C20C28, C20E58, D20B17 Exp. 12/31/21, G20D91 Exp. 04/30/22"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-228-2014", "product_description": "Mic 25/50/50 50ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "6 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205390"], "brand_name": ["VECURONIUM BROMIDE"], "generic_name": ["VECURONIUM BROMIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-781", "63323-782"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VECURONIUM BROMIDE"], "rxcui": ["859437"], "spl_id": ["ef0a4c9f-a65e-48dd-b625-eb76a18905f2"], "spl_set_id": ["d3163bdf-f163-41b5-a38a-3cd6fc1a50ba"], "package_ndc": ["63323-781-21", "63323-781-10", "63323-782-23", "63323-782-20"], "is_original_packager": [true], "unii": ["7E4PHP5N1D"]}, "product_type": "Drugs", "event_id": "78949", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0426-2018", "product_description": "Vecuronium bromide for Injection, 10 mg vials, Rx only, Mfd. for: Fresenius Kabi, Lake Zurich, IL 60047, Made in India,  NDC  63323-781-10", "product_quantity": "35,620 vials", "reason_for_recall": "Failed impurities/ degradation specifications: Out-of-specification (OOS) result for USP related compound F at the 12 month stability test station.", "recall_initiation_date": "20180116", "center_classification_date": "20180215", "termination_date": "20190917", "report_date": "20180207", "code_info": "Lot #:  ZG603, Exp 11/18", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1695-2019", "product_description": "PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0109-05", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "12 vials (15 mL each)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Cyclosporin (Grapeseed Oil) Ophthalmic  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-278-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "66 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@17, 6/7/2015, 04032015@26, 7/2/2015; 5012015@15, 7/30/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 60 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 35 mg/ml + Clonidine 1,200 mcg/ml + Baclofen 90 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1678-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 75 mg may have potentially been mislabeled as one of the following drugs:  guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: AD21790_58, EXP: 5/1/2014;  MIRTAZAPINE, Tablet, 7.5 mg, NDC 59762141509, Pedigree: W003693, EXP: 4/30/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "NORTRIPTYLINE HCL, Capsule, 75 mg has the following codes:   Pedigree: AD21790_73, EXP: 5/1/2014;  Pedigree: W003694, EXP: 6/26/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NORTRIPTYLINE HCL, Capsule, 75 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081301.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-829-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1230-2022", "product_description": "Testosterone Cypionate (GSO) 100mg/ml a)1mL-vial , b) 2mL-vial, Room temperature, Tailor Made Compounding", "product_quantity": "273 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: a) 12212109A2, Exp 6/19/2022; 01312217A1, Exp 7/30/2022; b) 10202108A1, Exp 4/18/2022; 12012125A, Exp 5/30/2022 ;02182230A1, Exp 8/17/2022; 10202108A1; 03022222A1, Exp 8/29/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-649-2013", "product_description": "Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCCIBC:20, Exp date: 3/28/2013 and Lot number CABDAEAC:90, Exp date: 3/5/2013."}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89717", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "N/A", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0721-2022", "product_description": "T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL packaged as a) 5 mL Multi-dose NDC 73198-0005-05; b) 10 mL Multi-dose NDC 73198-0005-10; Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 0.5% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.", "product_quantity": "1093 vials", "reason_for_recall": "Super Potent", "recall_initiation_date": "20220308", "center_classification_date": "20220329", "termination_date": "20231004", "report_date": "20220330", "code_info": "Lots: a) E41F10 Exp. 5/10/22; b) E41G10 Exp. 5/10/22"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80213", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0884-2018", "product_description": "0.9% Sodium Chloride Injection, USP, 100 mL bag, Rx Only ,Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7984-37", "product_quantity": "1247200 bags", "reason_for_recall": "Lack of assurance of sterility: Bags have potential to leak.", "recall_initiation_date": "20180531", "center_classification_date": "20180620", "termination_date": "20200604", "report_date": "20180627", "code_info": "Lot #: 85-021-JT, Exp 01/012020; 86-001-JT, Exp 02/01/2020"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA087702"], "brand_name": ["DEXAMETHASONE SODIUM PHOSPHATE"], "generic_name": ["DEXAMETHASONE SODIUM PHOSPHATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-0367", "0641-6145", "0641-6146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["DEXAMETHASONE SODIUM PHOSPHATE"], "rxcui": ["309696", "1116927", "1812194"], "spl_id": ["84665497-7e82-4733-bcfd-3177817ac0b3"], "spl_set_id": ["0277cc0a-2fd4-4605-a310-b613be84ee26"], "package_ndc": ["0641-0367-21", "0641-0367-25", "0641-6145-01", "0641-6145-25", "0641-6146-01", "0641-6146-10", "0641-6146-25"], "is_original_packager": [true], "unii": ["AI9376Y64P"]}, "product_type": "Drugs", "event_id": "78415", "recalling_firm": "West-Ward Pharmaceuticals Corp.", "address_1": "401 Industrial Way West", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0094-2018", "product_description": "Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 0641-6146-01), packaged in 25 x 5 mL Vials per shelf pack (NDC 0641-6146-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.", "product_quantity": "1,896 shelf packs", "reason_for_recall": "Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).", "recall_initiation_date": "20171106", "center_classification_date": "20171122", "termination_date": "20200401", "report_date": "20171129", "code_info": "Lot #: 106352, Exp 10/18"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; PIMOZIDE Tablet, 1 mg (1/2 of 2 mg) may be potentially mislabeled as    METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 63304057901, Pedigree: AD73525_52, EXP: 5/30/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "PIMOZIDE, Tablet, 1 mg (1/2 of 2 mg) has the following code    Pedigree: AD73525_61, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PIMOZIDE Tablet, 1 mg (1/2 of 2 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 57844018701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-632-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0576-2017", "product_description": "TRI-BLEACHING CREAM HQ (retinoic Acid 0.05%, Hydroquinone 6%, Fluocinolone 0.01%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA203314"], "brand_name": ["TRESIBA"], "generic_name": ["INSULIN DEGLUDEC"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2550", "0169-2660", "0169-2662"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DEGLUDEC"], "rxcui": ["1670011", "1670016", "1670021", "1670023", "2107520", "2107522"], "spl_id": ["e5571110-ca7e-4fcc-88a8-9f1d0104c508"], "spl_set_id": ["456c5e87-3dfd-46fa-8ac0-c6128d4c97c6"], "package_ndc": ["0169-2660-15", "0169-2660-90", "0169-2660-97", "0169-2550-13", "0169-2550-90", "0169-2550-97", "0169-2662-11", "0169-2662-90"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["54Q18076QB"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0619-2021", "product_description": "TRESIBA FlexTouch (insulin degludec injection) 100 units/mL (U-100), 3 mL Prefilled Pen,  Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Movo Mordisk Inc., Plainsboro, NJ 08536, NDC 0169-2660-90 (Pen), NDC 0169-2660-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JP52771 exp 09/30/2021;  JP53136 exp 06/30/2021;   KP50575 exp 01/31/2022;   KP50976 exp 01/31/2022;   KP51813 exp 04/30/2022;   KP52035 exp 04/30/2022;   KP52117 exp 04/30/2022;   KP52440 exp 06/30/2022;   KP52461 exp 04/30/2022;   KP52616 exp 06/30/2022;  JP52361 exp 08/01/2021"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88843", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0073-2022", "product_description": "AERO Tab PAIN RELIEVER (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets Per Packet, Packaged in 10,000 Packets/Case, PO# 11938, Mfg. for: Aero Healthcare, Valley Cottage, NY 10989  (Shipping Label )", "product_quantity": "1,480,981 tablets", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.", "recall_initiation_date": "20211013", "center_classification_date": "20211026", "termination_date": "20220328", "report_date": "20211103", "code_info": "Lot #: K-1278, exp. date 23-Jul; K-9371, AK-9463, exp. date 21-Nov; AK-9821, AK-9819, exp. date 22-Sep; 1107, exp. date 23-Mar."}, {"status": "Terminated", "city": "Waco", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74623", "recalling_firm": "Allergan Sales, LLC", "address_1": "8301 Mars Dr", "address_2": "N/A", "postal_code": "76712-6578", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0099-2017", "product_description": "TAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic Use, packaged in a) 30 g tubes (NDC: 0023-8335-03, UPC: 300238335036) and b)100 g tubes,(NDC: 0023-8335-10, UPC: 300238335104), Manufactured by: Allergan Inc., Irvine, CA 92512.", "product_quantity": "25,247 tubes (19,499 30 gram/ 5,748 100 gram)", "reason_for_recall": "Failed Content Uniformity Specifications", "recall_initiation_date": "20160630", "center_classification_date": "20161013", "termination_date": "20171206", "report_date": "20161019", "code_info": "a) Lot# 82579; Exp. 10/16  b) Lot:# 85088 Exp. 05/17"}, {"status": "Ongoing", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94838", "recalling_firm": "GLOBAL WIDGET LLC", "address_1": "8419 Sunstate St", "address_2": "", "postal_code": "33634-1306", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0614-2024", "product_description": "Nature's Script CBD Cryotherapy Pain Relief Roll on (menthol 4%) 200mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, UPC code: 8-40078-56731-5", "product_quantity": "2466 bottles", "reason_for_recall": "Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.", "recall_initiation_date": "20240625", "center_classification_date": "20240722", "report_date": "20240731", "code_info": "Lot #: 230346, Exp. date Aug 2025; 230090 Exp. date Feb 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0644-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Birth Ease, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955500223, NDC 57955-5002-2", "product_quantity": "89 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060316D Exp. 06/19"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0401-2024", "product_description": "fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095,  NDC 70004-0251-64, Bar Code 70004025164", "product_quantity": "130 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048722, Exp 11/29/23; 1223049096, Exp 12/15/23", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0808-2020", "product_description": "Liothyronine (T3) 92.5 MCG", "product_quantity": "4 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61024:99 Use by: 02/20/2020"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94648", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to CA, FL, OK, KS and CT", "recall_number": "D-0505-2024", "product_description": "Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03", "product_quantity": "66 bottles of 30 tablets", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240510", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot #: J2022G, Exp: 01/01/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0269-2015", "product_description": "HCG 10,000 U/ 10 mL PF Inj, 8Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-5012-34", "product_quantity": "3 vials", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141015FF, 11/15/14; 141024KK, 11/24/14; 141031CC, 12/1/14", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Sufentanil Citrate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0808-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0112-2020", "product_description": "Vitamin 5 B, 30 mL Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674253", "product_quantity": "616 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "New Philadelphia", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86712", "recalling_firm": "H & H Remedies, LLC", "address_1": "1219 S Broadway St", "address_2": "", "postal_code": "44663-9565", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0071-2021", "product_description": "Union (black) salve packaged in a) 1/8 oz; b) 2 oz.; c) 4 oz.; d) 8 oz.; e) 16 oz.; and f) 32 oz. jars. Mfg & Sold by: H & H Remedies, LLC c/o David A. Cox, 1219 South Broadway, New Philadelphia, OH 44663", "product_quantity": "939 jars", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201021", "center_classification_date": "20201109", "termination_date": "20240512", "report_date": "20201118", "code_info": "Lot #: H20-01S thru H20-12S", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075895"], "brand_name": ["SEVOFLURANE"], "generic_name": ["SEVOFLURANE"], "manufacturer_name": ["Baxter Healthcare Company"], "product_ndc": ["10019-651", "10019-655"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["SEVOFLURANE"], "rxcui": ["200243"], "spl_id": ["38ec52d9-7e61-4ce8-bdf1-37449f215817"], "spl_set_id": ["ea8bf997-2c71-4014-b18d-4f7ab45dfa19"], "package_ndc": ["10019-651-64", "10019-655-06"], "is_original_packager": [true], "upc": ["0310019651644"], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["38LVP0K73A"]}, "product_type": "Drugs", "event_id": "83055", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1435-2019", "product_description": "Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64", "product_quantity": "5940 bottles", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20190613", "center_classification_date": "20190628", "termination_date": "20200429", "report_date": "20190619", "code_info": "Lot #: S110F822 Exp. 5/31/2021"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0250-2017", "product_description": "B-Complex (30 ML), (Thiamine HCL 100 mg/Riboflavin-5-Phosphate 2 mg/Pyridoxine HCL 2 mg/Niacinamide 100 mg/Methylcobalamin 300 mcg/ml). Compounded by Tri-Coast Pharmacy.", "product_quantity": "67 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.      Known lot codes (Exp Date): 07262016E (12/31/2016), 10262016E (02/28/2017)."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA202331"], "brand_name": ["EDARBYCLOR"], "generic_name": ["AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)"], "product_ndc": ["60631-412", "60631-425"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AZILSARTAN KAMEDOXOMIL", "CHLORTHALIDONE"], "rxcui": ["1235144", "1235150", "1235151", "1235157"], "spl_id": ["26b92714-c5ea-943d-e063-6394a90a8341"], "spl_set_id": ["e60f795b-fce3-4361-aa03-f143451689d1"], "package_ndc": ["60631-412-30", "60631-425-30"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0431-2021", "product_description": "edarbyclor Azilsartan Medoxomil and Chlorthalidone Tablets 40 mg*/25 mg *Each tablet contains: 42.68 mg azilsartan kamedoxomil (equivalent to 40 mg azilsartan medoxomil) and 25 mg chlorthalidone. 30 Tablets Rx Only NDC 60631-425-30 Manufactured for Arbor Pharmaceuticals Atlanta, GA 30328", "product_quantity": "273 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "79551"}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0757-2016", "product_description": "Hydromorphone HCL 25 mg/ml/Bupivacaine HCL 4 mg/ml,   vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0465-2021", "product_description": "CIPROFLOX/D5W 400/200 24X200ML; NDC/UPC 36000000924; RX; IV SOLUTION (PIGGYBACK)", "product_quantity": "40 bags", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "A0D0924A"}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0527-2024", "product_description": "NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Tube 4 oz (113.39 g), Mfr. for Golden Tiger USA Albuq, NM, UPC 1 82294 00002 4", "product_quantity": "3,000", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 01623C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0673-2022", "product_description": "Clobetasol Propionate Ointment USP, 0.05%, packaged in a) 15 grams tube, NDC 52565-039-15; b) 30 grams tube, NDC 52565-039-30; c) 45 grams tube, NDC 52565-039-45; d) 60 grams tube, NDC 52565-039-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ  08310.", "product_quantity": "72,826 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15856, Exp. 8/31/2022; 17026, Exp. 6/30/2023; b) 15856, Exp. 8/31/2022; 17026, Exp. 6/30/2023; 17046, Exp. 6/30/2023; c) 15856, Exp. 8/31/2022; d) 15856, Exp. 8/31/2022; 17026, Exp. 6/30/2023"}, {"country": "United States", "city": "Parsippany", "address_1": "400 Interpace Pkwy", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).", "address_2": "", "product_quantity": "2543 bottles", "code_info": "L503092, Exp 04/2016", "center_classification_date": "20160824", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NJ", "product_description": "Hydrocortisone and acetic acid otic solution, Rx only, 10 mL bottle, Distributed by Actavis Inc. 60 Columbia Road Bldg B. Morristown, NJ 07560 USA , NDC 45963-412-61", "report_date": "20160831", "classification": "Class III", "openfda": {}, "recalling_firm": "Actavis Inc", "recall_number": "D-1472-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74902", "termination_date": "20170208", "more_code_info": "", "recall_initiation_date": "20160802", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0279-2020", "product_description": "S-PROCAINE HCL 2% BUFFERED, Rx Only, a) PFV-single dose 10ml  b)MDV 30ml glass vial, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:a)  S04162019DH@04, Exp 8/16/19;S04182019DT@11, Exp 8/18/19; S04302019DT@08, Exp 8/30/19; S05292019DT@11, Exp 9/29/19; S06092019DH@08, Exp 10/9/19, S06252019DH@15, Exp 10/25/19; S07022019DH@10, Exp 11/2/19, S07292019DH@11, Exp 11/29/19;   b) S06032019DT@02, Exp 10/3/19;  S07232019DH@03, Exp 11/23/19"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-059-2014", "product_description": "Betamethasone 7mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "932 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Anaheim", "address_1": "1250 N Lakeview Ave Ste O", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "address_2": "", "product_quantity": "9 bottles consisting of 90 tables each bottle", "code_info": "Lot # G2017F  NDC 68788-6882-9", "center_classification_date": "20180817", "distribution_pattern": "Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.", "state": "CA", "product_description": "Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9", "report_date": "20180829", "classification": "Class II", "openfda": {}, "recalling_firm": "Preferred Pharmaceuticals, Inc", "recall_number": "D-1107-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80840", "termination_date": "20190118", "more_code_info": "", "recall_initiation_date": "20180815", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Tempe", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96735", "recalling_firm": "SAINI TRADE INC", "address_1": "1405 N Scottsdale Rd", "address_2": "", "postal_code": "85288-1714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0466-2025", "product_description": "ULTRA ARMOR, My Armor My Power, Dietary Supplement, 10 capsules per box, Distributed by Health Fixer, Tempe, AZ 85288, UPC B0CYJ7Y5H9.", "product_quantity": "500 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.", "recall_initiation_date": "20250414", "center_classification_date": "20250611", "report_date": "20250618", "code_info": "All lots Lot #: KT-1ST-43-01-10/2025, Exp. 01/10/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0719-2023", "product_description": "vancomycin added to dextrose 5%, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6073-1.", "product_quantity": "13772 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883198, 37-883202, 37-883203, 37-883204, Exp 04/30/2023; 37-883799, Exp 05/02/2023; 37-884159, Exp 05/03/2023; 37-884888, 37-884892, 37-884899, 37-884901, Exp 05/07/2023; 37-886836, 37-886855, 37-886861, Exp 05/15/2023; 37-887381, Exp 05/16/2023; 37-887664, Exp 05/17/2023; 37-888256, 37-888259, 37-888267, Exp 05/21/2023; 37-888624, 37-888625, Exp 05/22/2023; 37-890038, 37-890041, 37-890042, Exp 05/28/2023; 37-890331, 37-890336, 37-890350, Exp 05/29/2023; 37-891163, Exp 05/31/2023; 37-892008, 37-892012, 37-892015, Exp 06/05/2023; 37-892882, 37-892884, Exp 06/07/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0021-2024", "product_description": "fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3", "product_quantity": "476, 50 mL Syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275464, Exp. 10/4/2023; 17-275850, Exp. 10/11/2023."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0187-2019", "product_description": "0.9% Sodium Chloride for Injection, 50 mL bags, Pharm D Solutions, Houston, Texas --- NDC 69699-1426-10", "product_quantity": "12 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04192018:13 Discard by: 10/16/2018"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL MIST"], "generic_name": ["OXYMETAZOLINE HCL"], "manufacturer_name": ["CVS Pharmacy"], "product_ndc": ["59779-388"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["a863b440-d02d-472b-873e-5561dc8eadbb"], "spl_set_id": ["b71c557a-eb93-40d1-87c4-847f5468fc1e"], "package_ndc": ["59779-388-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0615-2022", "product_description": "No Drip Nasal Mist, Oxymetazoline HCl 0.05% Nasal decongestant, 1 FL Oz (30 mL) per bottle,  Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 59779-388-10", "product_quantity": "64,512 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1FK1164, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0060-2016", "product_description": "CALM ME VITAMIN COCKTAIL, MAGNESIUM, COMPOUNDED B COMPLEX,  Injectable Solution, 30 mL vial, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t06112015@21, t06172015@43, t07062015@30"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20171204@117, BUD 06/02/2018; 20180129@14, BUD 07/28/2018; 20171011@111, BUD 04/09/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Estradiol 15 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0675-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-116-2014", "product_description": "HCG 200 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2692 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0674-2022", "product_description": "Clobetasol Propionate Gel, 0.05%, packaged in a) 15 grams tube, NDC 52565-082-15; b) 30 grams tube, NDC 52565-082-30; c) 60 grams tube, NDC 52565-082-60, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310.", "product_quantity": "81,883 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15063, Exp. 2/28/2022; 15928, Exp. 9/30/2022; 16432, Exp. 2/28/2023; 16769, Exp. 4/30/2023; b) 15243, Exp. 2/28/2022; 16628, Exp. 3/31/2023; c) 15064, 15286, 15287, Exp. 2/28/2022; 16173, Exp. 11/30/2022; 16628, Exp. 3/31/2023"}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["POVIDONE-IODINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-939"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["312564"], "spl_id": ["129c8b5c-88ca-c276-e063-6294a90a993f"], "spl_set_id": ["c9036a83-22f5-4a09-b01c-7093d4192c19"], "package_ndc": ["53329-939-04", "53329-939-06", "53329-939-08", "53329-939-23", "53329-939-25", "53329-939-69", "53329-939-13"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "97486", "recalling_firm": "Medline Industries, LP", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0674-2025", "product_description": "READYPREP PVP, Povidone-Iodine 10% Solution, Topical Antiseptic, Not Sterile, 1 Gallon (3.78 L) per bottle, Manufactured in USA by Medline Industries, LP., Three Lakes Drive, Northfield, IL 60093, NDC 53329-939-25", "product_quantity": "2,680 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20250819", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 24EJA180, Exp 06/01/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-014-2013", "product_description": "Lutera (levonorgestrel and ethinyl estradiol) Tablets USP, 0.1 mg/0.02 mg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA; Distributed by: Watson Pharma, Inc., Parsippany, NJ  07054 USA; NDC 52544-949-28.", "product_quantity": "67,860 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot #: 517921AA, 517921AB, 517922AA, 517922AB, 517923AA, 517923AB, Exp 03/31/14"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "66816", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US nationwide (including PR)", "recall_number": "D-1058-2014", "product_description": "Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66", "product_quantity": "14,357 bottles", "reason_for_recall": "Failed Dissolution Specification; 8 hr stability timepoint", "recall_initiation_date": "20131104", "center_classification_date": "20140203", "termination_date": "20150624", "report_date": "20140212", "code_info": "Lot V120131", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0715-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 10 mg/250 mL* (40 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6058-1.", "product_quantity": "6407 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-884272, Exp 05/03/2023; 37-887513, Exp 05/16/2023; 37-888083, Exp 05/18/2023; 37-889123, 37-889423, Exp 05/23/2023; 37-891563, Exp 06/01/2023; 37-892577, 37-892582, Exp 06/06/2023; 37-893248, 37-893257, Exp 06/08/2023; 37-894436, Exp 06/13/2023; 37-895805, Exp 06/19/2023; 37-898324, Exp 06/28/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83497", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1841-2019", "product_description": "Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.", "product_quantity": "8187 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.", "recall_initiation_date": "20190806", "center_classification_date": "20190823", "termination_date": "20220728", "report_date": "20190904", "code_info": "Lot #s: a) 091307A, Exp. 9/19; 101097A, Exp. 10/19; b) 091277A, Exp. 9/19."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202868"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-357"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312504"], "spl_id": ["b0251572-aa7f-434a-a7ff-33ccbc37dfaf"], "spl_set_id": ["5b054142-7372-4641-be27-dca630a97ad9"], "package_ndc": ["68462-357-90", "68462-357-01", "68462-357-05"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "94715", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0604-2024", "product_description": "Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-01", "product_quantity": "285,840 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240530", "center_classification_date": "20240717", "report_date": "20240724", "code_info": "Lot#:  17221446, 17221445, Exp May-31-24; 17221393, 17221403, 17221405, 17221503, 17221508, Exp Jun-30-24; 17221567, 17221566, 17221719, 17221731, Exp Jul-31-24; 17221891, 17221892, 17221900, 17221992, 17222022, Exp Aug-31-24; 17222056, 17222043, 17222068, 17222079, 17222099, 17222103, 17222114, 17222119, 17222188, 17222199, 17222209, 17222200, Exp Sep-30-24; 17222265, 17222269, Exp Oct-31-24; 17222527, 17222530, 17222583, 17222586, 17230051, 17230075, 17230067, Exp Nov-30-24;", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1362-2016", "product_description": "0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, a) 250 mL Hospira LifeCare Bag (NDC 61553-197-50), b) 250 mL Hospira LifeCare Bag (NDC\t61553-197-50), c) 150 mL Baxter Intravia Bag (NDC 61553-189-48), d) 250 mL Baxter VIAFLEX Bag ( NDC 61553-197-02), e) 250 mL White Smiths Medical Cassette (NDC 615530-933-11) f) 250 mL Yellow Smiths Medical Cassette (NDC 61553-190-50), Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141\t;", "product_quantity": "2,194 bags and cassettes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2H8197 , Lot Number 160730048M , Exp. Date 6/12/2016 ;  Service Code 2H8197 , Lot Number 160840111M , Exp. Date 6/22/2016 ;  Service Code 2H8197 , Lot Number 160870066M , Exp. Date 6/25/2016 ;  Service Code 2H8197 , Lot Number 160880208M , Exp. Date 6/27/2016 ;  Service Code 2H8197 , Lot Number 160910038M , Exp. Date 6/29/2016 ;  Service Code 2K8189 , Lot Number 160730049M , Exp. Date 6/11/2016 ;  Service Code 2K8189 , Lot Number 160810152M , Exp. Date 6/20/2016 ;  Service Code 2K8189 , Lot Number 160820330M , Exp. Date 6/21/2016 ;  Service Code 2K8189 , Lot Number 160940135M , Exp. Date 7/3/2016 ;  Service Code 2K8189 , Lot Number 160960178M , Exp. Date 7/5/2016 ;  Service Code 2K8189 , Lot Number 160970201M , Exp. Date 7/6/2016 ;  Service Code 2K8197 , Lot Number 160660178M , Exp. Date 6/5/2016 ;  Service Code 2K8197 , Lot Number 160670161M , Exp. Date 6/6/2016 ;  Service Code 2K8197 , Lot Number 160730253M , Exp. Date 6/12/2016 ;  Lot # 160770186M; Exp. 06/16   Lot # 160810189M; Exp. 06/16   Lot # 160840050M; Exp. 06/16   Lot # 160890231M; Exp. 06/16   Lot # 160910228M; Exp. 06/16  Lot # 160560020M; Exp. 05/16   Lot # 160610020C; Exp. 05/16   Lot # 160630014C; Exp. 06/16   Lot # 160660007C; Exp. 06/16   Lot # 160670052C; Exp. 06/16   Lot # 160680067C; Exp. 06/16  Lot # 160740037C; Exp. 06/16   Lot # 160740038C; Exp. 06/16   Lot # 160810067C; Exp. 06/16  Lot # 160840174M; Exp. 06/16   Lot # 160880157M; Exp. 06/16  Lot # 169000103M; Exp. 06/16   Lot # 160600222M; Exp. 05/16   Lot # 160740168M; Exp. 05/16   Lot # 160810051C ;Exp. 05/16  Lot # 160830031C; Exp. 06/16  Lot # 160880019C; Exp. 06/16  Lot # 160880175M; Exp. 06/16  Lot # 160950002C; Exp. 06/16   Lot # 160960172M; Exp. 07/16  Lot # 160950133M; Exp. 07/16", "more_code_info": ""}]